Stakeholders' feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines.

Autor:	Foroutan N; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada. foroutn@mcmaster.ca.; Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada., Tarride JE; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada.; Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada., Xie F; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada.; Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada.; Program for Health Economics and Outcome Measures (PHENOM), Hamilton, ON, Canada., Jameel B; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada., Mills F; Innomar Consulting, Oakville, ON, Canada., Levine M; Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, ON, Canada.; Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, ON, Canada.
Jazyk:	angličtina
Zdroj:	Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique [J Popul Ther Clin Pharmacol] 2020 Jan 03; Vol. 27 (1), pp. e1-e24. Date of Electronic Publication: 2020 Jan 03.
DOI:	10.15586/jptcp.v27i1.651
Abstrakt:	Introduction: The present study aimed to obtain Canadian stakeholders' feedback on a list of proposed recommendations for updating the Patented Medicine Prices Review Board (PMPRB)'s 2007 budget impact analysis (BIA) guidelines. Methods: A mixed-methods study was designed to obtain feedback from two stakeholder perspectives-(public and private) payers and manufacturers-on the proposed BIA recommendations. We obtained policymakers' opinion through one-on-one interviews and collected feedback from manufacturers and their consultants using a survey. The interview guide and the survey were developed based on the list of recommendations related to BIA key elements, which were either not discussed or addressed differently in the PMPRB 2007 BIA guidelines. The list was derived from 16 Canadian or other national and transnational BIA guidelines. A thematic analysis was applied for analysis of the qualitative (interview) data. Results: Thirty-five policymakers and manufacturers participated in the study. Stakeholders supported the inclusion of 56% of the proposed recommendations into the guidelines pertaining to the use of expert opinions, data extrapolated from the payers' database, scenario analysis, and dynamic population. Inclusion of indirect costs, and cost transfers from other jurisdictions, were not approved. There was no consensus regarding the inclusion of patients' adherence/compliance and cost offsets. Conclusions: The present study has provided sufficient insights to enable the creation of a penultimate version for updating the PMPRB BIA guidelines. This penultimate version will be subject to a broader consultation among stakeholders prior to a final revision and approval. Further Canadian stakeholder feedback is required for reaching consensus on inconclusive recommendations. Competing Interests: Naghmeh Foroutan, Jean-Eric Tarride, Feng Xie, and Bismah Jameel have no conflicts of interest that are directly relevant to the contents of this article. Mitchell Levine is the chair of the PMPRB, and Fergal Mills is a director at Innomar Consulting. (© 2020 Journal of Population Therapeutics and Clinical Pharmacology. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu